CPAP APAP denied as not FDA-approved for this use by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for cpap apap are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Denied Your CPAP/APAP as "Not FDA-Approved" — and How to Appeal

For CPAP and APAP devices, a "not FDA-approved" denial from UHC is almost always based on a documentation gap or a coding issue rather than the actual regulatory status of the device. All CPAP and APAP devices legally sold in the United States must be FDA-cleared as Class II medical devices. When UHC issues this type of denial, the most common causes are: (1) the device was billed under a HCPCS code that does not match the actual device provided; (2) the claim lacked documentation linking the device to an FDA-recognized indication; or (3) the specific device model is not identifiable in UHC's system as FDA-cleared for the claimed use.

## Why This Denial Is Appealable

Because CPAP and APAP are FDA-cleared devices for obstructive sleep apnea, a "not FDA-approved" denial is factually rebutted by the device's FDA clearance documentation. The appeal is straightforward: obtain the device's clearance information from the manufacturer and submit it alongside the clinical documentation showing the device was prescribed for its cleared indication.

## Federal Appeal Framework

• ERISA §503: Employer-sponsored plan members are entitled to a full-and-fair review in which a clinically qualified reviewer — not the original denying party — examines the regulatory and clinical evidence.
• ACA §2719 / External Review: If your internal appeals are denied, request IRO review within approximately four months of your final internal denial. Verify the exact deadline on the denial notice.
• Expedited review: If you are currently without effective treatment for OSA and the delay poses a clinical risk, document the urgency and request expedited review.

## Concrete Appeal Steps and Timeline

1. Obtain the specific UHC medical policy cited in the denial letter and identify the exact regulatory criterion at issue. 2. Contact the device manufacturer to obtain the FDA 510(k) clearance number and indication statement for the specific device model you received. 3. Confirm with the DME supplier that the HCPCS billing code matches the device provided — correct any coding error. 4. File the Level 1 internal appeal with the FDA clearance documentation and corrected claim (if applicable) within the deadline on the denial letter (typically 180 days). 5. If denied, file for external review within four months of the final internal denial.

## Documentation to Gather

• FDA clearance documentation: The device manufacturer's 510(k) summary or clearance letter identifying the specific model and its cleared indication. Your DME supplier should have this or can obtain it from the manufacturer.
• Prescriber order and diagnosis: A written order referencing the OSA diagnosis and the specific device, showing the device was prescribed for its cleared indication.
• Sleep study report: Confirming the OSA diagnosis that justifies the device.
• Corrected claim or billing attestation: If a HCPCS code error contributed to the denial, include the corrected code and the supplier's written confirmation.
• Medical-necessity letter: From the prescribing physician, confirming the diagnosis and that the ordered device is an FDA-cleared treatment for the documented condition.

## Criteria-Mapping Structure

Pull each criterion from UHC's coverage policy related to FDA clearance/approval requirements. In a table, map each criterion to the supporting exhibit: FDA clearance letter, prescribing information, diagnosis documentation. If the denial was triggered by a billing code, include a row showing the original code, the error, the corrected code, and the basis for the correction. This structured rebuttal leaves no ambiguity for the reviewer.